Antibiotic + Steroid — a detailed guide to composition, benefits, and use.
Advanced combination of Moxifloxacin and Loteprednol Etabonate for effective antibacterial and anti-inflammatory therapy with reduced IOP risk.
Ocugram-LX Eye Drop pairs the fourth-generation fluoroquinolone Moxifloxacin Hydrochloride 0.5% w/v with the soft corticosteroid Loteprednol Etabonate 0.5% w/v. Loteprednol Etabonate is uniquely designed to provide potent anti-inflammatory activity at the ocular surface while undergoing rapid metabolic inactivation upon systemic absorption, significantly reducing the risk of intraocular pressure (IOP) elevation commonly associated with conventional corticosteroids. This combination is ideal for managing ocular surface diseases requiring both antimicrobial and anti-inflammatory therapy where steroid安全性 is a concern.
| Composition | Moxifloxacin Hydrochloride 0.5% w/v + Loteprednol Etabonate 0.5% w/v |
| Volume | 5 mL per bottle |
| pH Range | 6.5 - 7.4 |
| Dosage Form | Ophthalmic suspension |
| Storage | Store at 2-25°C. Do not freeze. |
| Shelf Life | 24 months from date of manufacture |
| Packaging | 5 mL sterile ophthalmic suspension bottle |
| Dosage | 1 drop in the affected eye(s) 3-4 times daily, tapering as directed by physician |
Explore the complete product page for packaging, dosing, and enquiry options.
View Ocugram-LX Eye Drop Enquire NowDiscover more insights on eye health and ophthalmic care.